S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
Potential Gold Rush For Investors Sparked By USA Vs. China Trade War (Ad)
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
Copper Exploration Heating Up (Ad)
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
How This Rare Metal Is Going To Solve A $173 TRILLION World Problem… And Could Benefit Investors (Ad)
S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
Potential Gold Rush For Investors Sparked By USA Vs. China Trade War (Ad)
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
Copper Exploration Heating Up (Ad)
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
How This Rare Metal Is Going To Solve A $173 TRILLION World Problem… And Could Benefit Investors (Ad)
S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
Potential Gold Rush For Investors Sparked By USA Vs. China Trade War (Ad)
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
Copper Exploration Heating Up (Ad)
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
How This Rare Metal Is Going To Solve A $173 TRILLION World Problem… And Could Benefit Investors (Ad)
S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
Potential Gold Rush For Investors Sparked By USA Vs. China Trade War (Ad)
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
Copper Exploration Heating Up (Ad)
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
How This Rare Metal Is Going To Solve A $173 TRILLION World Problem… And Could Benefit Investors (Ad)
NYSE:ZBH

Zimmer Biomet - ZBH Stock Forecast, Price & News

$113.16
-0.10 (-0.09%)
(As of 08/8/2022 12:00 AM ET)
Add
Compare
Today's Range
$113.00
▼
$114.37
50-Day Range
$101.65
▼
$122.07
52-Week Range
$100.39
▼
$153.76
Volume
534,218 shs
Average Volume
1.57 million shs
Market Capitalization
$23.74 billion
P/E Ratio
103.82
Dividend Yield
0.85%
Price Target
$133.50

Zimmer Biomet MarketRank™ Forecast

Analyst Rating
Hold
2.22 Rating Score
Upside/​Downside
18.0% Upside
$133.50 Price Target
Short Interest
Healthy
1.27% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.33
Upright™ Environmental Score
News Sentiment
0.17mentions of Zimmer Biomet in the last 14 days
Based on 31 Articles This Week
Insider Trading
Selling Shares
$55,872 Sold Last Quarter
Proj. Earnings Growth
4.42%
From $6.79 to $7.09 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.34 out of 5 stars

Medical Sector

419th out of 1,293 stocks

Surgical Appliances & Supplies Industry

11th out of 27 stocks

See Top Rated MarketRank™ Stocks Here
ZBH stock logo

About Zimmer Biomet (NYSE:ZBH) Stock

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Analyst Ratings Changes

Several research analysts recently weighed in on the stock. Truist Financial dropped their price objective on shares of Zimmer Biomet to $115.00 in a research report on Friday, July 22nd. Citigroup boosted their price objective on shares of Zimmer Biomet from $114.00 to $119.00 in a research report on Wednesday, August 3rd. Needham & Company LLC cut shares of Zimmer Biomet from a "buy" rating to a "hold" rating in a research report on Friday, May 27th. Morgan Stanley boosted their price objective on shares of Zimmer Biomet from $115.00 to $120.00 and gave the stock an "equal weight" rating in a research report on Wednesday, August 3rd. Finally, Stifel Nicolaus dropped their price objective on shares of Zimmer Biomet from $140.00 to $120.00 in a research report on Monday, July 18th. Two equities research analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat, Zimmer Biomet has an average rating of "Hold" and an average price target of $133.50.

Zimmer Biomet Stock Down 0.1 %

NYSE:ZBH traded down $0.10 on Monday, reaching $113.16. The company had a trading volume of 534,218 shares, compared to its average volume of 1,571,989. The firm has a market capitalization of $23.74 billion, a price-to-earnings ratio of 103.82, a price-to-earnings-growth ratio of 3.36 and a beta of 1.15. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.95 and a current ratio of 1.81. Zimmer Biomet has a 1-year low of $100.39 and a 1-year high of $153.76. The company's fifty day moving average is $109.22 and its 200-day moving average is $117.57.

Zimmer Biomet (NYSE:ZBH - Get Rating) last announced its earnings results on Tuesday, August 2nd. The medical equipment provider reported $1.82 earnings per share for the quarter, topping analysts' consensus estimates of $1.65 by $0.17. The firm had revenue of $1.78 billion during the quarter, compared to analyst estimates of $1.72 billion. Zimmer Biomet had a net margin of 3.10% and a return on equity of 12.20%. The company's revenue for the quarter was up 1.0% compared to the same quarter last year. During the same period in the prior year, the business earned $1.90 EPS. On average, research analysts forecast that Zimmer Biomet will post 6.79 earnings per share for the current fiscal year.

Zimmer Biomet Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, July 29th. Investors of record on Monday, June 27th were paid a $0.24 dividend. This represents a $0.96 dividend on an annualized basis and a yield of 0.85%. The ex-dividend date of this dividend was Friday, June 24th. Zimmer Biomet's payout ratio is presently 88.07%.

Insider Buying and Selling

In other news, insider Zuilen Wilfred Van sold 531 shares of the stock in a transaction dated Tuesday, July 5th. The shares were sold at an average price of $105.22, for a total transaction of $55,871.82. Following the completion of the transaction, the insider now directly owns 2,240 shares in the company, valued at approximately $235,692.80. The transaction was disclosed in a document filed with the SEC, which is available at this link. Company insiders own 0.73% of the company's stock.

Receive ZBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zimmer Biomet and its competitors with MarketBeat's FREE daily newsletter.

ZBH Stock News Headlines

August 5, 2022 | americanbankingnews.com
Zimmer Biomet (NYSE:ZBH) PT Raised to $120.00
August 5, 2022 | americanbankingnews.com
Oppenheimer Research Analysts Cut Earnings Estimates for Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
August 4, 2022 | americanbankingnews.com
Zimmer Biomet (NYSE:ZBH) Price Target Raised to $119.00 at Citigroup
August 4, 2022 | americanbankingnews.com
Piper Sandler Lowers Zimmer Biomet (NYSE:ZBH) Price Target to $120.00
August 2, 2022 | finance.yahoo.com
Zimmer Biomet Raises FY22 Outlook As Q2 Performance Exceeds Expectations
August 2, 2022 | finance.yahoo.com
Zimmer Biomet (ZBH) Q2 Earnings Top Estimates, 2022 View Up
August 2, 2022 | nasdaq.com
Zimmer Biomet Gains On Q2 Earnings, Guidance
August 2, 2022 | finance.yahoo.com
Zimmer Biomet (ZBH) Surpasses Q2 Earnings and Revenue Estimates
August 2, 2022 | markets.businessinsider.com
Zimmer Biomet Holdings Inc. Bottom Line Rises In Q2
August 2, 2022 | finance.yahoo.com
Zimmer Biomet Announces Second Quarter 2022 Financial Results
July 31, 2022 | americanbankingnews.com
Zimmer Biomet (ZBH) Set to Announce Quarterly Earnings on Tuesday
July 28, 2022 | finance.yahoo.com
Zimmer Biomet and Hospital for Special Surgery (HSS) Announce Creation of the HSS/Zimmer Biomet Innovation Center for Artificial Intelligence in Robotic Joint Replacement
July 26, 2022 | finance.yahoo.com
Earnings Preview: Zimmer Biomet (ZBH) Q2 Earnings Expected to Decline
July 26, 2022 | americanbankingnews.com
Zimmer Biomet (NYSE:ZBH) Price Target Lowered to $115.00 at Truist Financial
July 25, 2022 | americanbankingnews.com
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Receives $137.40 Average PT from Brokerages
July 21, 2022 | marketwatch.com
Zimmer Biomet Holdings Inc. stock outperforms market on strong trading day
July 18, 2022 | americanbankingnews.com
Morgan Stanley Cuts Zimmer Biomet (NYSE:ZBH) Price Target to $115.00
July 16, 2022 | americanbankingnews.com
Analysts Set Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Price Target at $139.90
July 15, 2022 | marketwatch.com
Zimmer Biomet Holdings Inc. stock rises Friday, still underperforms market
July 15, 2022 | markets.businessinsider.com
What 4 Analyst Ratings Have To Say About Zimmer Biomet Holdings
July 15, 2022 | finance.yahoo.com
Zimmer Biomet Holdings, Inc.: Looking for more favorable entry point
July 6, 2022 | finance.yahoo.com
The Returns At Zimmer Biomet Holdings (NYSE:ZBH) Aren't Growing
July 5, 2022 | finance.yahoo.com
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2022 Financial Results
June 30, 2022 | finance.yahoo.com
Zimmer Biomet Announces Creation of Independent 501(c)(3) Movement is Life Coalition
June 21, 2022 | morningstar.com
Zimmer Biomet Holdings Inc - Stock Valuation ZBH
See More Headlines
Receive ZBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zimmer Biomet and its competitors with MarketBeat's FREE daily newsletter.

ZBH Company Calendar

Ex-Dividend for 7/29 Dividend
6/24/2022
Dividend Payable
7/29/2022
Last Earnings
8/02/2022
Today
8/09/2022
Next Earnings (Estimated)
11/03/2022
Fiscal Year End
12/31/2022
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Surgical appliances & supplies
Sub-Industry
N/A
Sector
Medical
Current Symbol
NYSE:ZBH
Previous Symbol
NYSE:ZMH
CUSIP
N/A
CIK
1136869
Web
www.zimmerbiomet.com
Phone
(574) 267-6131
Fax
574-372-4988
Employees
19,500
Year Founded
1927

Price Target and Rating

Average Stock Price Forecast
$133.50
High Stock Price Forecast
$186.00
Low Stock Price Forecast
$111.00
Forecasted Upside/Downside
+18.0%
Consensus Rating
Hold
Rating Score (0-4)
2.22
Research Coverage
23 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$1.09
Trailing P/E Ratio
103.82
Forward P/E Ratio
16.67
P/E Growth
3.36
Net Income
$401.60 million
Net Margins
3.10%
Pretax Margin
4.41%
Return on Equity
12.20%
Return on Assets
6.67%

Debt

Debt-to-Equity Ratio
0.43
Current Ratio
1.81
Quick Ratio
0.95

Sales & Book Value

Annual Sales
$7.84 billion
Price / Sales
3.03
Cash Flow
$12.60 per share
Price / Cash Flow
8.98
Book Value
$60.63 per share
Price / Book
1.87

Miscellaneous

Outstanding Shares
209,820,000
Free Float
208,288,000
Market Cap
$23.74 billion
Optionable
Optionable
Beta
1.15

Social Links


Key Executives

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













ZBH Stock - Frequently Asked Questions

Should I buy or sell Zimmer Biomet stock right now?

23 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Zimmer Biomet in the last year. There are currently 2 sell ratings, 14 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ZBH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ZBH, but not buy additional shares or sell existing shares.
View ZBH analyst ratings or view top-rated stocks.

What is Zimmer Biomet's stock price forecast for 2022?

23 equities research analysts have issued 1-year target prices for Zimmer Biomet's shares. Their ZBH share price forecasts range from $111.00 to $186.00. On average, they expect the company's stock price to reach $133.50 in the next twelve months. This suggests a possible upside of 18.0% from the stock's current price.
View analysts price targets for ZBH or view top-rated stocks among Wall Street analysts.

How has Zimmer Biomet's stock performed in 2022?

Zimmer Biomet's stock was trading at $127.04 at the beginning of the year. Since then, ZBH shares have decreased by 10.9% and is now trading at $113.16.
View the best growth stocks for 2022 here.

When is Zimmer Biomet's next earnings date?

Zimmer Biomet is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our ZBH earnings forecast.

How were Zimmer Biomet's earnings last quarter?

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) posted its quarterly earnings data on Tuesday, August, 2nd. The medical equipment provider reported $1.82 earnings per share for the quarter, beating analysts' consensus estimates of $1.65 by $0.17. The medical equipment provider earned $1.78 billion during the quarter, compared to analysts' expectations of $1.72 billion. Zimmer Biomet had a trailing twelve-month return on equity of 12.20% and a net margin of 3.10%. The firm's revenue for the quarter was up 1.0% compared to the same quarter last year. During the same period last year, the firm posted $1.90 earnings per share.
Read the conference call transcript.

How often does Zimmer Biomet pay dividends? What is the dividend yield for Zimmer Biomet?

Zimmer Biomet announced a quarterly dividend on Tuesday, May 17th. Stockholders of record on Monday, June 27th will be paid a dividend of $0.24 per share on Friday, July 29th. This represents a $0.96 annualized dividend and a dividend yield of 0.85%. The ex-dividend date of this dividend is Friday, June 24th.
Read our dividend analysis for ZBH.

Is Zimmer Biomet a good dividend stock?

Zimmer Biomet (NYSE:ZBH) pays an annual dividend of $0.96 per share and currently has a dividend yield of 0.85%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 88.07%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, ZBH will have a dividend payout ratio of 13.54% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for ZBH.

What guidance has Zimmer Biomet issued on next quarter's earnings?

Zimmer Biomet issued an update on its FY 2022 earnings guidance on Tuesday, August, 2nd. The company provided earnings per share (EPS) guidance of $6.70-$6.90 for the period, compared to the consensus EPS estimate of $6.72. The company issued revenue guidance of $7.76 billion-$7.91 billion, compared to the consensus revenue estimate of $6.83 billion.

What is Bryan Hanson's approval rating as Zimmer Biomet's CEO?

240 employees have rated Zimmer Biomet Chief Executive Officer Bryan Hanson on Glassdoor.com. Bryan Hanson has an approval rating of 87% among the company's employees. 66.0% of employees surveyed would recommend working at Zimmer Biomet to a friend.

What other stocks do shareholders of Zimmer Biomet own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Zimmer Biomet investors own include AT&T (T), Walt Disney (DIS), Johnson & Johnson (JNJ), Bristol-Myers Squibb (BMY), Cisco Systems (CSCO), Merck & Co., Inc. (MRK), Intel (INTC), AbbVie (ABBV), NVIDIA (NVDA) and JPMorgan Chase & Co. (JPM).

What is Zimmer Biomet's stock symbol?

Zimmer Biomet trades on the New York Stock Exchange (NYSE) under the ticker symbol "ZBH."

Who are Zimmer Biomet's major shareholders?

Zimmer Biomet's stock is owned by many different retail and institutional investors. Top institutional investors include Ceredex Value Advisors LLC (0.91%), Allspring Global Investments Holdings LLC (0.85%), Van ECK Associates Corp (0.71%), Douglas Lane & Associates LLC (0.30%), Sumitomo Mitsui Trust Holdings Inc. (0.28%) and Nuance Investments LLC (0.22%). Insiders that own company stock include Arthur J Higgins, Aure Bruneau, Bryan C Hanson, Chad F Phipps, Chad F Phipps, Didier Deltort, Sang Yi and Zuilen Wilfred Van.
View institutional ownership trends.

How do I buy shares of Zimmer Biomet?

Shares of ZBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Zimmer Biomet's stock price today?

One share of ZBH stock can currently be purchased for approximately $113.16.

How much money does Zimmer Biomet make?

Zimmer Biomet (NYSE:ZBH) has a market capitalization of $23.74 billion and generates $7.84 billion in revenue each year. The medical equipment provider earns $401.60 million in net income (profit) each year or $1.09 on an earnings per share basis.

How many employees does Zimmer Biomet have?

Zimmer Biomet employs 19,500 workers across the globe.

Does Zimmer Biomet have any subsidiaries?

The following companies are subsidiares of Zimmer Biomet: Abbott Spine, Beijing Montagne Medical Device Co. Ltd., Beijing Montagne Medical Device Co. Ltd., BioMet, Biomet 3i Australia Pty. Ltd., Biomet 3i Belgium N.V., Biomet 3i Benelux Holdings N.V., Biomet 3i Dental Iberica SL, Biomet 3i LLC, Biomet 3i Mexico S.A. de C.V., Biomet 3i Netherlands B.V., Biomet 3i Nordic AB, Biomet 3i Portugal Lda, Biomet 3i Switzerland GmbH, Biomet 3i Turkey, Biomet 3i UK Ltd., Biomet 3i do Brasil Comercio de Aparelhos Medicos Ltda., Biomet Acquisitions (Unlimited), Biomet Argentina SA, Biomet Australia Pty. Ltd., Biomet Biologics LLC, Biomet Brazil Medical Device Ltda., Biomet C.V., Biomet CV Holdings LLC, Biomet Cementing Technologies AB, Biomet Chile SA, Biomet China Co. Ltd., Biomet Deutschland GmbH, Biomet Deutschland Holding GmbH, Biomet Fair Lawn LLC, Biomet Finance US LLC, Biomet France Sarl, Biomet Global Supply Chain Center B.V., Biomet Healthcare Management GmbH, Biomet Holdings B.V., Biomet Hong Kong CBT Ltd., Biomet Hong Kong Holding Ltd., Biomet Hong Kong No. 1 Ltd., Biomet Inc., Biomet Insurance Ltd., Biomet International Inc., Biomet International Orthopedics LLC, Biomet Leasing Inc., Biomet Manufacturing LLC, Biomet Mexico S.A. de C.V., Biomet Microfixation B.V., Biomet Orthopedics LLC, Biomet Orthopedics Puerto Rico Inc., Biomet Spain Orthopaedics S.L., Biomet Sports Medicine LLC, Biomet Trauma LLC, Biomet U.S. Reconstruction LLC, Biomet UK Healthcare Ltd., Biomet UK Ltd., CD Diagnostics, CD Diagnostics Inc., CD Laboratories Inc., Cayenne Medical, Cayenne Medical Inc., CelgenTek Innovations Corporation, Centerpulse Ltd, Changzhou Biomet Medical Devices Co. Ltd., Citra Labs LLC, Clinical Graphics, Compression Therapy Concepts Inc., Compression Therapy Products, D.S. Comp Ltd., Dornoch Medical Systems, Dornoch Medical Systems Inc., EBI Holdings LLC, EBI LLC, EBI Medical Systems LLC, EBI Patient Care Inc., ETEX Corporation, ETEX Holdings Inc., Electro-Biology LLC, Endius, Espanormed S.L., Etex, ExtraOrtho, Hakuho Company Ltd., IC Guided Surgery SRL, Implant Concierge LLC, Implant Innovations Holdings LLC, Implex, InnoVision Inc., Interpore Cross International LLC, JERDS Luxembourg Holding Sarl, Kirschner Medical Corporation, Knee Creations, LDR Brasil Comercio Importacao e Exportacao Ltda., LDR Holding, LDR Medical Hong Kong (branch), LDR Médical S.A.S., LVB Acquisition Inc., Lanx Puerto Rico LLC , Lanx Srl, Medical Compression Systems Inc., Medtech SA, Medtech SAS, Medtech Surgical GmbH, Medtech Surgical Inc., NORMED Medizin-Technik GmbH, ORTHOsoft ULC, Ortho Transmission, Orthopaedic Advantage LLC, Ospol Participacoes Ltda., Representaciones Zimmer Inc. S. de R.L. de C.V., Respondwell, SM Re Ltd., Scandimed Holding AB, Shanghai Biomet Business Consulting Co. Ltd., Synvasive Technology, Synvasive Technology Inc., ZB COOP C.V., ZB COOP LLC, ZB Cayman (Asia) Holding Ltd., ZB Cayman Island CBT 2 Ltd., ZB Dental India Private Limited, ZB EMEA 1 LP, ZB EMEA Finance UK 1 Ltd., ZB EMEA Finance UK 2 Ltd., ZB EMEA Finance UK 3 Ltd., ZB EMEA US UK LLC, ZB Hong Kong CBT 2 Ltd., ZB Hong Kong Holding Ltd., ZB Hong Kong Ltd., ZB Manufacturing LLC, ZB UK Group Holdings Limited, ZH2LX Barbados Branch (branch), Zfx, Zfx GmbH, Zfx Innovation GmbH, Zhejiang Biomet Medical Products Co. Ltd., Zimmer (Shanghai) Medical International Trading Co. Ltd., Zimmer Asia (HK) Ltd., Zimmer Australia Holding Pty. Ltd., Zimmer Biomet (Thailand) Co. Ltd., Zimmer Biomet Asel Alarabiya Limited Company, Zimmer Biomet Asia Holding B.V., Zimmer Biomet Asia Holdings Pte. Ltd., Zimmer Biomet Austria GmbH, Zimmer Biomet BVBA, Zimmer Biomet CBT, Zimmer Biomet CBT 2, Zimmer Biomet CMF and Thoracic LLC, Zimmer Biomet Canada Inc., Zimmer Biomet Centroamerica SA, Zimmer Biomet Comp Ltd., Zimmer Biomet Denmark ApS, Zimmer Biomet Dental Canada Inc., Zimmer Biomet Dental K.K., Zimmer Biomet Deutschland GmbH, Zimmer Biomet Distribution LLC, Zimmer Biomet Finance Srl, Zimmer Biomet Finance US Holding Inc., Zimmer Biomet Finland Oy, Zimmer Biomet France Holdings SAS, Zimmer Biomet France SAS, Zimmer Biomet GK, Zimmer Biomet Global Holdings Switzerland GmbH, Zimmer Biomet Hellas SA, Zimmer Biomet Ireland Limited, Zimmer Biomet Italia Srl, Zimmer Biomet Korea Ltd., Zimmer Biomet Nederland B.V., Zimmer Biomet New Zealand Company, Zimmer Biomet Norway AS, Zimmer Biomet OUS Holdings AG, Zimmer Biomet Polska Sp. z.o.o, Zimmer Biomet Portugal Unipessoal Lda, Zimmer Biomet Pty. Ltd., Zimmer Biomet Romania S.R.L., Zimmer Biomet South Africa (Pty) Ltd., Zimmer Biomet Spain S.L., Zimmer Biomet Spine Inc., Zimmer Biomet Sweden AB, Zimmer Biomet Taiwan Co. Ltd., Zimmer Biomet UK Ltd., Zimmer Biomet US 2 Holding Inc., Zimmer CBT I Holding Inc., Zimmer CBT II Holding Inc., Zimmer CEP USA Holding Co., Zimmer CEP USA Inc., Zimmer CIS Ltd., Zimmer CV Inc., Zimmer Caribe LLC, Zimmer Cayman Islands Holding Co. Ltd., Zimmer Co-op Holdings LLC, Zimmer Colombia SAS, Zimmer Czech sro, Zimmer Dental (Shanghai) Medical Device Co. Ltd., Zimmer Dental Chile Spa, Zimmer Dental GmbH, Zimmer Dental Inc., Zimmer Dental Italy Srl, Zimmer Dental Ltd., Zimmer Dental SAS, Zimmer Finance Ireland, Zimmer France Manufacturing Sarl, Zimmer Germany Holdings GmbH, Zimmer GmbH, Zimmer GmbH Euro IP Branch (branch), Zimmer GmbH Winterthur Branch (branch), Zimmer Gulf FZ LLC, Zimmer Inc., Zimmer India Private Ltd., Zimmer International Logistics GmbH, Zimmer Investments LLC, Zimmer Knee Creations Inc., Zimmer Luxembourg II Sarl, Zimmer Luxembourg Sarl, Zimmer Manufacturing B.V., Zimmer Manufacturing B.V. (branch), Zimmer Medical Malaysia SDN BHD, Zimmer Netherlands Cooperatief U.A., Zimmer Orthobiologics Inc., Zimmer Orthopedics Manufacturing Limited, Zimmer Production Inc., Zimmer Pte. Ltd., Zimmer Slovakia sro, Zimmer Southeast Florida LLC, Zimmer Spine Next Inc., Zimmer Spine SAS, Zimmer Surgical, Zimmer Surgical Inc., Zimmer Surgical SA, Zimmer Switzerland Holdings LLC, Zimmer Switzerland Manufacturing GmbH, Zimmer Tibbi Cihazlar Sanayi ve Ticaret AS, Zimmer Trabecular Metal Technology Inc., Zimmer Trustee Ltd., Zimmer UK Limited, Zimmer US Inc., and Zimmer do Brasil Comercio Ltda..
Read More

When was Zimmer Biomet founded?

Zimmer Biomet was founded in 1927.

How can I contact Zimmer Biomet?

Zimmer Biomet's mailing address is 345 EAST MAIN STREET, WARSAW IN, 46580. The official website for the company is www.zimmerbiomet.com. The medical equipment provider can be reached via phone at (574) 267-6131, via email at keri.mattox@zimmerbiomet.com, or via fax at 574-372-4988.

This page (NYSE:ZBH) was last updated on 8/9/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.